Breast Cancer Risk Factors
Researchers at Weill Cornell Medical College, Department of Internal Medicine publish new data on breast cancer risk factors
Published in Women's Health Weekly, January 24th, 2008
Researchers detail in 'Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature,' new data in breast cancer. According to a study from the United States, "Aromatase inhibitors (AI's) are increasingly being incorporated in the treatment strategy for hormone receptor positive breast cancer either alone or in combination with chemotherapy, biologics in both the adjuvant and metastatic setting [1]. They markedly suppress plasma estrogen levels by inhibiting or inactivating aromatase, the enzyme responsible for the synthesis of estrogens from androgenic substrates [1]."
"Currently, the three selective...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Angiomyolipoma
New research demonstrates potential diagnosis, treatment benefits - Breast Cancer
Breast cancer risk varies among women who are carriers of BRCA1 and BRCA2 gene mutations - Breast Cancer
Breast cancer risk varies significantly among BRCA1 and BRCA2 carriers - Breast Cancer
Docetaxel given after doxorubicin reduces recurrence - Breast Cancer
Molecules can block breast cancer's ability to spread - Breast Cancer
Small RNAs can prevent spread of breast cancer - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
